Search

everythinglearnresearchcommunity

for

Search:↓

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Skin Radiance Collagen improved skin and hair health in adult females.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Hyperbaric oxygen therapy improves hair growth and quality of life in androgenic alopecia patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Nonshaven follicular unit extraction is a highly satisfactory method for restoring pubic hair.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

A new laser treatment may help regrow hair in men with pattern baldness and has minimal side effects.

PRP therapy is effective and safe for various skin and hair conditions.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Women with PCOS are more likely to experience sexual dysfunction, but lifestyle changes and weight loss can improve sexual function.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

AB+ blood group is more common in alopecia areata patients.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Finasteride may cause slight depression and anxiety.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.